Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway

Qiang Wan1, Zhongyong Liu2, Ming Yang3

  • 1Department of Medical Cardiology, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, 330006, China. wanqiang109559140@163.com.

Abstract

Insights

Triptolide prevents against PM2.5-induced podocyte injury by suppressing the NF-κB signaling pathway. This study investigates the protective effects of triptolide on podocyte damage caused by fine particulate matter (PM2.5).

Area of Science:

  • Nephrology
  • Environmental Health
  • Cell Biology

Background:

  • Particulate matter (PM2.5) exposure is linked to increased risk of membranous nephropathy (MN).
  • PM2.5's direct impact on podocyte injury, a key factor in MN, requires further investigation.
  • Triptolide, a traditional Chinese medicine component, is used for MN but its effect on PM2.5-induced podocyte injury is unknown.

Purpose of the Study:

  • To evaluate the effects of PM2.5 on podocyte injury.
  • To explore the potential protective effects of triptolide against PM2.5-induced podocyte damage.
  • To elucidate the underlying molecular mechanisms of triptolide's action.

Main Methods:

  • Podocytes were treated with PM2.5, with or without triptolide pre-treatment.
  • Cell viability, apoptosis, migration, lactate dehydrogenase (LDH), malondialdehyde (MDA), and superoxide dismutase (SOD) levels were assessed.
  • Cytoskeletal structure and protein expressions (nephrin, podocin, Bcl-2, Bax, NF-κB/p65, p-IκBα) were analyzed.

Main Results:

  • PM2.5 exposure caused significant podocyte injury, including cytoskeletal damage, increased apoptosis, elevated MDA and LDH, and altered protein expressions (increased Bax, NF-κB/p65, p-IκBα; decreased nephrin, podocin, Bcl-2).
  • PM2.5 also reduced cell viability, SOD levels, and migratory capacity.
  • Triptolide administration reversed these detrimental effects of PM2.5 on podocytes.

Conclusions:

  • Triptolide demonstrates a protective effect against PM2.5-induced podocyte injury.
  • The mechanism involves the suppression of the nuclear factor-kappa B (NF-κB) signaling pathway.
  • Findings suggest triptolide as a potential therapeutic agent for conditions involving PM2.5-related podocyte damage.